Report Detail

Request for Sample of this report

Other Global Nanomedicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4601976
    • |
  • 20 July, 2024
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Nanomedicine market size was valued at USD 160 million in 2023 and is forecast to a readjusted size of USD 242.6 million by 2030 with a CAGR of 6.1% during review period.
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
Nanomedicine refers to the application of nanotechnology in the field of medicine. It involves the use of nanoparticles, nanomaterials, and nanodevices to deliver drugs, diagnose diseases, and monitor the health of patients at the molecular level.

Nanoparticles and nanomaterials can be engineered to have specific properties, such as size, shape, and surface chemistry, which allow for targeted and controlled delivery of drugs to specific cells or tissues in the body. This targeted drug delivery system increases the efficiency and effectiveness of treatments while minimizing side effects.

In addition to drug delivery, nanomedicine also includes the development of nanosensors and nanodevices for diagnostic purposes. These tiny devices can detect molecular markers of diseases, such as proteins or genetic material, at an early stage, enabling early intervention and personalized medicine. Nanosensors can also be used to monitor the health of patients in real-time, providing continuous data on various health parameters.

Nanomedicine has the potential to revolutionize healthcare by providing more precise and personalized treatments. It has the potential to improve drug efficacy, reduce drug toxicity, and enhance patient outcomes. However, there are still challenges that need to be addressed, such as the safety and toxicity of nanoparticles, as well as regulatory approval processes for nano-based medical products.
The Global Info Research report includes an overview of the development of the Nanomedicine industry chain, the market status of oncology (Quantum dots, Nanoparticles), Infectious diseases (Quantum dots, Nanoparticles), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nanomedicine.
Regionally, the report analyzes the Nanomedicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nanomedicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nanomedicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nanomedicine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Quantum dots, Nanoparticles).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nanomedicine market.
Regional Analysis: The report involves examining the Nanomedicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nanomedicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nanomedicine:
Company Analysis: Report covers individual Nanomedicine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nanomedicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (oncology, Infectious diseases).
Technology Analysis: Report covers specific technologies relevant to Nanomedicine. It assesses the current state, advancements, and potential future developments in Nanomedicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nanomedicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nanomedicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Market segment by Application
oncology
Infectious diseases
Cardiology
Orthopedics
Others
Market segment by players, this report covers
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nanomedicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nanomedicine, with revenue, gross margin and global market share of Nanomedicine from 2019 to 2024.
Chapter 3, the Nanomedicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nanomedicine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nanomedicine.
Chapter 13, to describe Nanomedicine research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Nanomedicine
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Nanomedicine by Type
    • 1.3.1 Overview: Global Nanomedicine Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Nanomedicine Consumption Value Market Share by Type in 2023
    • 1.3.3 Quantum dots
    • 1.3.4 Nanoparticles
    • 1.3.5 Nanoshells
    • 1.3.6 Nanotubes
    • 1.3.7 Nanodevices
  • 1.4 Global Nanomedicine Market by Application
    • 1.4.1 Overview: Global Nanomedicine Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 oncology
    • 1.4.3 Infectious diseases
    • 1.4.4 Cardiology
    • 1.4.5 Orthopedics
    • 1.4.6 Others
  • 1.5 Global Nanomedicine Market Size & Forecast
  • 1.6 Global Nanomedicine Market Size and Forecast by Region
    • 1.6.1 Global Nanomedicine Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Nanomedicine Market Size by Region, (2019-2030)
    • 1.6.3 North America Nanomedicine Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Nanomedicine Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Nanomedicine Market Size and Prospect (2019-2030)
    • 1.6.6 South America Nanomedicine Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Nanomedicine Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Combimatrix
    • 2.1.1 Combimatrix Details
    • 2.1.2 Combimatrix Major Business
    • 2.1.3 Combimatrix Nanomedicine Product and Solutions
    • 2.1.4 Combimatrix Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Combimatrix Recent Developments and Future Plans
  • 2.2 Ablynx
    • 2.2.1 Ablynx Details
    • 2.2.2 Ablynx Major Business
    • 2.2.3 Ablynx Nanomedicine Product and Solutions
    • 2.2.4 Ablynx Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Ablynx Recent Developments and Future Plans
  • 2.3 Abraxis Bioscience
    • 2.3.1 Abraxis Bioscience Details
    • 2.3.2 Abraxis Bioscience Major Business
    • 2.3.3 Abraxis Bioscience Nanomedicine Product and Solutions
    • 2.3.4 Abraxis Bioscience Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Abraxis Bioscience Recent Developments and Future Plans
  • 2.4 Celgene
    • 2.4.1 Celgene Details
    • 2.4.2 Celgene Major Business
    • 2.4.3 Celgene Nanomedicine Product and Solutions
    • 2.4.4 Celgene Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Celgene Recent Developments and Future Plans
  • 2.5 Mallinckrodt
    • 2.5.1 Mallinckrodt Details
    • 2.5.2 Mallinckrodt Major Business
    • 2.5.3 Mallinckrodt Nanomedicine Product and Solutions
    • 2.5.4 Mallinckrodt Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Mallinckrodt Recent Developments and Future Plans
  • 2.6 Arrowhead Research
    • 2.6.1 Arrowhead Research Details
    • 2.6.2 Arrowhead Research Major Business
    • 2.6.3 Arrowhead Research Nanomedicine Product and Solutions
    • 2.6.4 Arrowhead Research Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Arrowhead Research Recent Developments and Future Plans
  • 2.7 GE Healthcare
    • 2.7.1 GE Healthcare Details
    • 2.7.2 GE Healthcare Major Business
    • 2.7.3 GE Healthcare Nanomedicine Product and Solutions
    • 2.7.4 GE Healthcare Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 GE Healthcare Recent Developments and Future Plans
  • 2.8 Merck
    • 2.8.1 Merck Details
    • 2.8.2 Merck Major Business
    • 2.8.3 Merck Nanomedicine Product and Solutions
    • 2.8.4 Merck Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Merck Recent Developments and Future Plans
  • 2.9 Pfizer
    • 2.9.1 Pfizer Details
    • 2.9.2 Pfizer Major Business
    • 2.9.3 Pfizer Nanomedicine Product and Solutions
    • 2.9.4 Pfizer Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Pfizer Recent Developments and Future Plans
  • 2.10 Nanosphere
    • 2.10.1 Nanosphere Details
    • 2.10.2 Nanosphere Major Business
    • 2.10.3 Nanosphere Nanomedicine Product and Solutions
    • 2.10.4 Nanosphere Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Nanosphere Recent Developments and Future Plans
  • 2.11 Epeius Biotechnologies
    • 2.11.1 Epeius Biotechnologies Details
    • 2.11.2 Epeius Biotechnologies Major Business
    • 2.11.3 Epeius Biotechnologies Nanomedicine Product and Solutions
    • 2.11.4 Epeius Biotechnologies Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Epeius Biotechnologies Recent Developments and Future Plans
  • 2.12 Cytimmune Sciences
    • 2.12.1 Cytimmune Sciences Details
    • 2.12.2 Cytimmune Sciences Major Business
    • 2.12.3 Cytimmune Sciences Nanomedicine Product and Solutions
    • 2.12.4 Cytimmune Sciences Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Cytimmune Sciences Recent Developments and Future Plans
  • 2.13 Nanospectra Biosciences
    • 2.13.1 Nanospectra Biosciences Details
    • 2.13.2 Nanospectra Biosciences Major Business
    • 2.13.3 Nanospectra Biosciences Nanomedicine Product and Solutions
    • 2.13.4 Nanospectra Biosciences Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Nanospectra Biosciences Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Nanomedicine Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Nanomedicine by Company Revenue
    • 3.2.2 Top 3 Nanomedicine Players Market Share in 2023
    • 3.2.3 Top 6 Nanomedicine Players Market Share in 2023
  • 3.3 Nanomedicine Market: Overall Company Footprint Analysis
    • 3.3.1 Nanomedicine Market: Region Footprint
    • 3.3.2 Nanomedicine Market: Company Product Type Footprint
    • 3.3.3 Nanomedicine Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Nanomedicine Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Nanomedicine Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Nanomedicine Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Nanomedicine Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Nanomedicine Consumption Value by Type (2019-2030)
  • 6.2 North America Nanomedicine Consumption Value by Application (2019-2030)
  • 6.3 North America Nanomedicine Market Size by Country
    • 6.3.1 North America Nanomedicine Consumption Value by Country (2019-2030)
    • 6.3.2 United States Nanomedicine Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Nanomedicine Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Nanomedicine Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Nanomedicine Consumption Value by Type (2019-2030)
  • 7.2 Europe Nanomedicine Consumption Value by Application (2019-2030)
  • 7.3 Europe Nanomedicine Market Size by Country
    • 7.3.1 Europe Nanomedicine Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Nanomedicine Market Size and Forecast (2019-2030)
    • 7.3.3 France Nanomedicine Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Nanomedicine Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Nanomedicine Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Nanomedicine Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Nanomedicine Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Nanomedicine Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Nanomedicine Market Size by Region
    • 8.3.1 Asia-Pacific Nanomedicine Consumption Value by Region (2019-2030)
    • 8.3.2 China Nanomedicine Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Nanomedicine Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Nanomedicine Market Size and Forecast (2019-2030)
    • 8.3.5 India Nanomedicine Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Nanomedicine Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Nanomedicine Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Nanomedicine Consumption Value by Type (2019-2030)
  • 9.2 South America Nanomedicine Consumption Value by Application (2019-2030)
  • 9.3 South America Nanomedicine Market Size by Country
    • 9.3.1 South America Nanomedicine Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Nanomedicine Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Nanomedicine Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Nanomedicine Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Nanomedicine Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Nanomedicine Market Size by Country
    • 10.3.1 Middle East & Africa Nanomedicine Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Nanomedicine Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Nanomedicine Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Nanomedicine Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Nanomedicine Market Drivers
  • 11.2 Nanomedicine Market Restraints
  • 11.3 Nanomedicine Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Nanomedicine Industry Chain
  • 12.2 Nanomedicine Upstream Analysis
  • 12.3 Nanomedicine Midstream Analysis
  • 12.4 Nanomedicine Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Nanomedicine. Industry analysis & Market Report on Nanomedicine is a syndicated market report, published as Global Nanomedicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Nanomedicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,686.56
    		4,029.84
    		5,373.12
    		3,201.60
    		4,802.40
    		6,403.20
    		530,108.40
    		795,162.60
    		1,060,216.80
    		292,772.40
    		439,158.60
    		585,544.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo